Firefly Neuroscience announced a strategic partnership with Zeto. Under the agreement, Firefly will act as a non-exclusive distributor of Zeto’s FDA-cleared EEG headset devices, cloud platform and services, expanding Firefly’s accessibility to healthcare providers and institutions. This collaboration will also integrate Firefly’s proprietary Brain Network Analytics technology with Zeto’s advanced EEG platform, which is currently being used in more than 200 hospitals and neurology offices across the country.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AIFF:
- Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto’s FDA-Cleared EEG Device Platform
- Firefly Neuroscience appoints Stella Vnook to board of directors
- Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors
- Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
- Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th